someone exiting last 2 days. Kind of annoying but presents a good buying opp 25K parcels keep dropping in. However doesnt change the company fundamentals.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling